Article Text

Download PDFPDF

Exacerbations in cystic fibrosis · 1: Epidemiology and pathogenesis
  1. Christopher H Goss1,
  2. Jane L Burns2
  1. 1Department of Medicine, University of Washington Medical Center, Seattle, Washington, USA
  2. 2Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA
  1. Correspondence to:
    Dr Christopher H Goss
    Department of Medicine, University of Washington Medical Center, Campus Box 356522, 1959 NE Pacific, Seattle, Washington 98195, USA; goss{at}u.washington.edu

Abstract

With the improving survival of patients with cystic fibrosis (CF), the clinical spectrum of this complex multisystem disease continues to evolve. One of the most important clinical events for patients with CF in the course of this disease is an acute pulmonary exacerbation. Clinical and microbial epidemiology studies of CF pulmonary exacerbations continue to provide important insight into the course, prognosis and complications of the disease. This review provides a summary of the pathophysiology, clinical epidemiology and microbial epidemiology of a CF pulmonary exacerbation.

  • ARIC, Acute Respiratory Illness Checklist
  • CF, cystic fibrosis
  • CFTR, cystic fibrosis transmembrane regulator
  • FEV1, forced expiratory volume in 1 s
  • IL, interleukin
  • MCBT, multiple combination bactericidal testing
  • RSSQ, Respiratory and Systemic Symptoms Questionnaire
  • TNFα, tumour necrosis factor α
View Full Text

Statistics from Altmetric.com

Footnotes

  • Support: Leroy Matthew Physician Scientist, Cystic Fibrosis Foundation; NIH (NHBLI) 1 K23 HL72017-01 (CG).

  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles